Get the Stockscreener App
6.71
31.05%
1.59
Verrica Pharmaceuticals Inc stock is traded at $6.71, with a volume of 1.15M.
It is up +31.05% in the last 24 hours and up +74.29% over the past month.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
See More
Previous Close:
$5.12
Open:
$5.56
24h Volume:
1.15M
Relative Volume:
3.76
Market Cap:
$63.68M
Revenue:
$5.12M
Net Income/Loss:
$-67.00M
P/E Ratio:
-4.5646
EPS:
-1.47
Net Cash Flow:
$-38.94M
1W Performance:
+49.78%
1M Performance:
+74.29%
6M Performance:
+9.69%
1Y Performance:
-39.55%
1-Day Range:
$5.50
$6.79
1-Week Range:
$3.90
$6.79
52-Week Range:
$3.28
$13.60
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
Name
Verrica Pharmaceuticals Inc
Sector
Industry
Phone
484-453-3300
Address
10 NORTH HIGH STREET, WEST CHESTER, PA
Compare VRCA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
6.71 | 48.59M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-25-23 | Upgrade | Needham | Hold → Buy |
| Mar-22-23 | Initiated | Jefferies | Buy |
| Feb-13-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-14-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-15-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-24-20 | Initiated | Northland Capital | Outperform |
| Mar-24-20 | Initiated | Needham | Buy |
| Feb-21-19 | Initiated | H.C. Wainwright | Buy |
View All
Verrica Pharmaceuticals Inc Stock (VRCA) Latest News
Insider Stock Purchases: November 26, 2025 - Quiver Quantitative
Verrica Pharmaceuticals Insider Bought Shares Worth $17,505,157, According to a Recent SEC Filing - MarketScreener
Verrica Pharmaceuticals announces $50M PIPE financing - MSN
Insider Buying: John Kirby Acquires Shares of Verrica Pharmaceuticals Inc (VRCA) - GuruFocus
Caligan Partners LP Significantly Increases Stake in Verrica Pha - GuruFocus
Verrica arranges $50M financing to pay off debt, pursue 'billion-dollar market opportunities' - The Business Journals
Watkins Advises on Verrica Pharmaceuticals’ US$50 Million Private Placement Financing - Latham & Watkins LLP
Is Verrica Pharmaceuticals Inc 1NE a good long term investmentPrice Channel Trading & Free Phenomenal Capital Appreciation - earlytimes.in
Verrica Pharmaceuticals Announces Financing of $50 Million - citybiz
Verrica Pharmaceuticals Secures $50M Financing Deal - TipRanks
Verrica Pharmaceuticals stock jumps after $50M financing deal By Investing.com - Investing.com Nigeria
Verrica Pharmaceuticals stock jumps after $50M financing deal - Investing.com India
Verrica Pharmaceuticals (VRCA) Secures $50 Million Through PIPE Deal - GuruFocus
Verrica Pharmaceuticals announces private placement financing of $50 million - TradingView
Verrica Pharmaceuticals (VRCA) Secures $50 Million Through PIPE Financing - GuruFocus
[8-K] Verrica Pharmaceuticals Inc. Reports Material Event | VRCA SEC FilingForm 8-K - Stock Titan
Verrica raises $50 million to repay debt, extend cash runway - Investing.com
Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and ... - Enidnews.com
Verrica (NASDAQ: VRCA) Announces $50M PIPE to Retire OrbiMed Debt, Extend Runway to 2027 - Stock Titan
Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MSN
Verrica Pharmaceuticals Inc. announced that it expects to receive $50.067383 million in funding from BKB Growth Investments, LLC and other investors - MarketScreener
Why Verrica Pharmaceuticals Inc. (1NE) stock is a must watch tickerWeekly Gains Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Verrica Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com
New Cancer Data Hints at a Surgery-Free Future — Verrica’s VP-315 Shows Big Promise - MSN
Verrica Posts Strong Q3 as YCANTH Momentum Builds and Late-Stage Pipeline Advances - MyChesCo
Can Verrica Pharmaceuticals Inc. (1NE) stock deliver consistent EPS growthInsider Buying & Long-Term Capital Growth Strategies - newser.com
How Verrica Pharmaceuticals Inc. (1NE) stock reacts to stronger dollarGold Moves & Short-Term Swing Trade Alerts - newser.com
How forex fluctuations impact Verrica Pharmaceuticals Inc. (1NE) stockJuly 2025 Fed Impact & Smart Money Movement Tracker - newser.com
What MACD trends signal for Verrica Pharmaceuticals Inc. (1NE) stockLayoff News & Reliable Breakout Forecasts - newser.com
Is Verrica Pharmaceuticals Inc. (1NE) stock a top hedge fund pickJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Can trapped investors hope for a rebound in Verrica Pharmaceuticals Inc.Portfolio Risk Report & Stepwise Entry and Exit Trade Signals - newser.com
What RSI levels show for Verrica Pharmaceuticals Inc. (1NE) stockTake Profit & Consistent Growth Equity Picks - newser.com
Is Verrica Pharmaceuticals Inc. stock a smart buy before Fed meeting2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Why analysts raise outlook for Verrica Pharmaceuticals Inc. (1NE) stock - newser.com
Why retail traders accumulate Verrica Pharmaceuticals Inc. (1NE) stockMarket Performance Summary & Verified Technical Signals - newser.com
Verrica Pharmaceuticals Inc. (VRCA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Published on: 2025-11-19 05:26:49 - newser.com
Should I buy Verrica Pharmaceuticals Inc. (1NE) stock before earnings seasonDollar Strength & Capital Efficiency Focused Ideas - newser.com
Why analysts recommend Verrica Pharmaceuticals Inc. (1NE) stockLong Setup & Weekly Top Gainers Alerts - newser.com
What Fibonacci levels say about Verrica Pharmaceuticals Inc. reboundWeekly Gains Report & Precise Swing Trade Alerts - newser.com
Verrica Pharmaceuticals Inc Stock (VRCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.76%
2.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):